A

Amylyx Pharmaceuticals

AMLX

2.06500
USD
0.015
(0.73%)
Market Open
Volume
24,901
EPS
0
Div Yield
0
P/E
-2
Market Cap
391,133,779
News

Title: Amylyx Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder.